Delphi Panel Size: How Many Experts Should Be on a Delphi Panel?
Delphi Panel Size: How Many Experts Should Be on a Delphi Panel? One of the most common questions when planning a Delphi study is: “How many experts do we need on the panel?” Determining the appropriate Delphi panel size in a Delphi study is an important design decision. The answer is not as straightforward as many researchers…
Practical Delphi Applications for Academic Researchers
Practical Delphi Applications for Academic Researchers Healthcare research is increasingly being conducted in areas where evidence is limited, clinical practice varies, or innovation is evolving faster than formal guidance. In these situations, researchers often need structured ways to gather expert opinion, identify priorities, and establish consensus. This is where the Delphi methodology has become particularly…
How to Map Evidence Gaps to Support a Successful Launch
How to Map Evidence Gaps to Support a Successful Launch For Medical Affairs, generating clinical data alone is rarely enough to ensure the successful adoption of a therapy. Randomised clinical trials establish safety and efficacy, but they do not always answer the practical questions clinicians face in real-world practice. As a result, even therapies…
Designing Global Delphi Panels to Deliver Actionable Insights
Designing Global Delphi Panels to Deliver Actionable Insights Pharmaceutical companies, medical affairs teams, and guideline developers frequently require global or multi-regional consensus to: Inform global clinical guidelines and align recommendations across markets Support regulatory and payer engagement with robust international perspectives Enable effective product launches, aligned messaging, and pertinent educational initiatives Identify implementation barriers…
Why Are Patient-Reported Outcomes Becoming Increasingly Important For Medical Affairs?
Why are patient-reported outcomes becoming increasingly important for medical affairs? Real-world evidence (RWE) has moved from a supporting role in drug development to a strategic pillar across the product lifecycle. As regulators and health technology assessment (HTA) bodies demand more patient-centred evidence, Medical Affairs teams recognise the need to gather insights directly from patients….
How to Improve HCP Engagement using Consensus Insights
How to Improve HCP Engagement using Consensus Insights Engaging healthcare professionals (HCPs) is a challenge for medical affairs and market access teams. Today’s HCPs seek trusted, practical insights grounded in real-world experience. Overwhelmed by data, they need medical and market access teams to move beyond sharing information to supporting clinical clarity, peer alignment, and…
A Guide to Using Consensus Methods in Integrated Evidence Planning
A Practical Guide to Using Consensus Methods in Integrated Evidence Planning Consensus methods provide Medical Affairs teams with a practical, scientifically rigorous approach to bridging evidence gaps that clinical trials and real-world studies alone may not fully address. By systematically capturing and synthesizing expert insights, these methods can help establish best practices, shape treatment…
Why Integrate Consensus Studies into Evidence Generation Strategy
Why integrate consensus studies into evidence generation strategy Medical Affairs plays a pivotal role in shaping clinical practice through evidence generation strategy. While randomized controlled trials (RCTs), real-world evidence (RWE) and health economics data remain foundational, consensus studies are increasingly recognized for their value in addressing evidence gaps that traditional studies cannot. Integrating consensus…
From Consensus to Impact: How Publication Extenders Can Support Change
From Consensus to Impact: How Publication Extenders Can Support Change Reaching consensus through structured methodologies like Delphi panels can often be a key step toward creating meaningful change in clinical practice. Expert opinion, when systematically captured, can provide a solid foundation for guideline development, policy change, and improved care pathways. But achieving and publishing…
Real World Evidence – And Other Ways of Changing Healthcare
Real World Evidence – And Other Ways of Changing Healthcare As the healthcare landscape grows more complex and data-driven, so too must the methods used to generate evidence. Traditionally, randomized controlled trials (RCTs) have been held as the gold standard, valued for minimizing bias and demonstrating causality. However, their design is based on highly…